SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013247
Filing Date
2020-11-09
Accepted
2020-11-09 07:31:28
Documents
60
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20200930x10q.htm   iXBRL 10-Q 1195184
2 EX-31.1 zyne-20200930xex31d1.htm EX-31.1 11632
3 EX-31.2 zyne-20200930xex31d2.htm EX-31.2 11369
4 EX-32.1 zyne-20200930xex32d1.htm EX-32.1 6092
5 EX-32.2 zyne-20200930xex32d2.htm EX-32.2 6113
6 GRAPHIC zyne-20200930x10q001.jpg GRAPHIC 75771
  Complete submission text file 0001558370-20-013247.txt   5464836

Data Files

Seq Description Document Type Size
7 EX-101.SCH zyne-20200930.xsd EX-101.SCH 36294
8 EX-101.CAL zyne-20200930_cal.xml EX-101.CAL 43027
9 EX-101.DEF zyne-20200930_def.xml EX-101.DEF 134538
10 EX-101.LAB zyne-20200930_lab.xml EX-101.LAB 313546
11 EX-101.PRE zyne-20200930_pre.xml EX-101.PRE 266248
12 EXTRACTED XBRL INSTANCE DOCUMENT zyne-20200930x10q_htm.xml XML 1018048
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 201296101
SIC: 2834 Pharmaceutical Preparations